Nanopublications

@prefix this: <http://purl.org/np/RA_oI-ncugFmT2Sae4sIvA5x79B79QFxBP8K68MO35Gbs> .
@prefix sub: <http://purl.org/np/RA_oI-ncugFmT2Sae4sIvA5x79B79QFxBP8K68MO35Gbs#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix umls: <http://identifiers.org/umls/> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix unii: <http://identifiers.org/unii/> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-11T07:14:02.124516"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 ;
    prov:wasQuotedFrom " Carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40%. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. It is indicated for the management of essential. essential. heart failure." .
  biolink: pav:version "2.3.0" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" ;
    npx:hasSignature "U/r65UOfFROfafNoL599E6jgtio6BnZAIOQ1yWdFWz31jXT3rO1XdUkfRnFBq0DJBvvLCK6Kgx3dPyzLSxzt4c9/yLUpeWGwA2P6nHElBdOI3E2TPwHNUPGoPM7kjPyL2Jvb6GbpBIpfxJ1oDg7V3VISyL+TYzo8C4zyPsuOawgFdwpv5GRmVcxQikIyseagaWl8jyXG8m67wo16NoNUUoT4UACC70paz+bzcSlgcVxCe4y5TL+nXAzUCM9T8KvBMe714vlQ8/duaRBOhT2Qy0N6qB5gdFeDOWCqvH3VFUtSqqaEQSrrIFvOCO3Ydiuu8DRsmg69hVheB/qGTG5vUA==" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2022-10-11T07:14:02.124516"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}